192,894 Shares in Option Care Health, Inc. $OPCH Bought by Fideuram Intesa Sanpaolo Private Banking S.P.A.

Fideuram Intesa Sanpaolo Private Banking S.P.A. purchased a new position in Option Care Health, Inc. (NASDAQ:OPCH) in the first quarter, Holdings Channel reports. The fund purchased 192,894 shares of the company’s stock, valued at approximately $5,193,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Norges Bank acquired a new stake in Option Care Health during the 4th quarter worth $61,787,000. Gamco Investors INC. ET AL increased its holdings in shares of Option Care Health by 36.8% in the fourth quarter. Gamco Investors INC. ET AL now owns 369,002 shares of the company’s stock worth $11,756,000 after acquiring an additional 99,244 shares in the last quarter. Victory Capital Management Inc. increased its holdings in shares of Option Care Health by 129.5% in the third quarter. Victory Capital Management Inc. now owns 383,605 shares of the company’s stock worth $10,649,000 after acquiring an additional 216,489 shares in the last quarter. Geneva Capital Management LLC raised its position in shares of Option Care Health by 27.6% during the third quarter. Geneva Capital Management LLC now owns 1,369,862 shares of the company’s stock worth $38,027,000 after purchasing an additional 296,216 shares during the period. Finally, Game Creek Capital LP acquired a new stake in shares of Option Care Health during the third quarter worth about $1,527,000. 98.05% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. bought 36,610 shares of the firm’s stock in a transaction that occurred on Monday, May 4th. The stock was acquired at an average cost of $21.41 per share, with a total value of $783,820.10. Following the transaction, the director directly owned 450,000 shares of the company’s stock, valued at approximately $9,634,500. This represents a 8.86% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Timothy P. Sullivan purchased 24,154 shares of the company’s stock in a transaction that occurred on Thursday, May 7th. The shares were purchased at an average cost of $20.69 per share, for a total transaction of $499,746.26. Following the completion of the purchase, the director owned 73,383 shares in the company, valued at $1,518,294.27. This trade represents a 49.06% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have bought a total of 73,264 shares of company stock worth $1,548,316 over the last quarter. Company insiders own 1.70% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. Bank of America cut shares of Option Care Health from a “buy” rating to a “neutral” rating and set a $22.00 price target for the company. in a report on Friday, May 1st. Truist Financial set a $30.00 target price on shares of Option Care Health in a report on Friday, May 1st. Weiss Ratings cut Option Care Health from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 11th. Stephens set a $30.00 target price on Option Care Health in a report on Friday, May 1st. Finally, The Goldman Sachs Group started coverage on Option Care Health in a report on Monday, June 8th. They set a “neutral” rating and a $22.00 target price on the stock. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $30.54.

Option Care Health Price Performance

NASDAQ OPCH opened at $21.90 on Friday. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.64 and a quick ratio of 1.07. Option Care Health, Inc. has a fifty-two week low of $18.01 and a fifty-two week high of $36.80. The stock has a market capitalization of $3.44 billion, a PE ratio of 16.98, a PEG ratio of 1.22 and a beta of 0.65. The business has a fifty day moving average price of $21.67 and a two-hundred day moving average price of $28.26.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Thursday, April 30th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.03. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.39 billion. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.Option Care Health’s revenue was up 1.3% compared to the same quarter last year. During the same period last year, the firm posted $0.40 earnings per share. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Equities analysts expect that Option Care Health, Inc. will post 1.64 earnings per share for the current fiscal year.

Option Care Health Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.